Patent Reform Bill Sets Excessively High Bar For Injunctions, Attorney Says
Executive Summary
Tightened injunctive relief standards included in a House patent reform bill could be detrimental to the pharmaceutical industry, Sidley Austin Brown & Wood Partner Jeffrey Kushan stated
You may also be interested in...
Patent Reform Bill Drops Changes To Injunctive Relief In Revised Draft
The latest draft of Rep. Lamar Smith's (R-Texas) "Patent Reform Act" drops proposed changes to injunctive relief standards that had been opposed by the pharmaceutical industry
Patent Reform Bill Drops Changes To Injunctive Relief In Revised Draft
The latest draft of Rep. Lamar Smith's (R-Texas) "Patent Reform Act" drops proposed changes to injunctive relief standards that had been opposed by the pharmaceutical industry
Patent Reform Consensus Supports New Reexamination System, Sen. Hatch
Initial patent reform consensus supports a new system for patent reexamination, Senate Judiciary Intellectual Property Subcommittee Chairman Orrin Hatch (R-Utah) said April 25